Author:
Wurz Gregory T.,Emshoff Vernon D.,DeGregorio Michael W.,Wiebe Valerie J.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference18 articles.
1. Baker WJ, Wiebe VJ, Koester SK, et al (1992) Toremifene enhances doxorubicin accumulation, inhibits protein kinase C (PKC) activity, increases PKC message, and enhances cytotoxicity in a tumor-bearing multidrug-resistant nude mouse model. Proc Am Soc Clin Oncol 11: 109
2. Chabner BA, Fojo A (1989) Multidrug resistance: P-glycoprotein and its allies, the elusive foes. J Natl Cancer Inst 81: 910?913
3. Cornwell MM, Gottesman MM, Pastan I (1986) Increased vinblastine binding to membrane vesicles from multidrug resistant KB cells. J Biol Chem 261: 7921?7928
4. DeGregorio MW, Carrera CJ, Klock JC, Wilbur JR (1982) Uptake and metabolism of daunorubicin by human leukemia cells. Cancer Chemother Pharmacol 10: 29?32
5. DeGregorio MW, Ford JM, Benz CC, Wiebe VJ (1989) Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistance. J Clin Oncol 7: 1359?1364
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献